Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scheich

Showing results (361-370 of 384) with videos related to

Pageof 39
Sort By:
Neurobiology of Disease|December 3, 2013
Disrupted cross-laminar cortical processing in β amyloid pathology precedes cell deathH Lison, M F K Happel, F Schneider, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2020
Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2AKamonwan Fish, Federico Comoglio, Arthur L Shaffer, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2016
Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrBMichael F Mesleh, Jason B Cross, Jing Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
RHOA controls oncogenic B cell receptor signaling in aggressive lymphomaAriana N Jacobs, Dominique Jahn, Tim Beringer, et al.
Cell Reports|May 16, 2019
Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous TransplantationChristina A Ortmann, Lena Dorsheimer, Khalil Abou-El-Ardat, et al.
Biochemical Pharmacology|June 17, 2020
Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in ratsSzilvia B László, Bernadette Lázár, Gábor B Brenner, et al.
Cancer Cell|June 21, 2024
IRF4 requires ARID1A to establish plasma cell identity in multiple myelomaArnold Bolomsky, Michele Ceribelli, Sebastian Scheich, et al.
Nature Communications|August 4, 2019
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AMLThomas Oellerich, Constanze Schneider, Dominique Thomas, et al.
Cancer Discovery|April 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell LymphomaSean R Corcoran, James D Phelan, Jaewoo Choi, et al.
Cancer Cell|May 3, 2024
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomasJaewoo Choi, Michele Ceribelli, James D Phelan, et al.
Pageof 39

Showing results (361-370 of 384) with videos related to

Sort By:
Pageof 39
Neurobiology of Disease|December 3, 2013
Disrupted cross-laminar cortical processing in β amyloid pathology precedes cell deathH Lison, M F K Happel, F Schneider, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2020
Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2AKamonwan Fish, Federico Comoglio, Arthur L Shaffer, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2016
Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrBMichael F Mesleh, Jason B Cross, Jing Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
RHOA controls oncogenic B cell receptor signaling in aggressive lymphomaAriana N Jacobs, Dominique Jahn, Tim Beringer, et al.
Cell Reports|May 16, 2019
Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous TransplantationChristina A Ortmann, Lena Dorsheimer, Khalil Abou-El-Ardat, et al.
Biochemical Pharmacology|June 17, 2020
Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in ratsSzilvia B László, Bernadette Lázár, Gábor B Brenner, et al.
Cancer Cell|June 21, 2024
IRF4 requires ARID1A to establish plasma cell identity in multiple myelomaArnold Bolomsky, Michele Ceribelli, Sebastian Scheich, et al.
Nature Communications|August 4, 2019
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AMLThomas Oellerich, Constanze Schneider, Dominique Thomas, et al.
Cancer Discovery|April 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell LymphomaSean R Corcoran, James D Phelan, Jaewoo Choi, et al.
Cancer Cell|May 3, 2024
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomasJaewoo Choi, Michele Ceribelli, James D Phelan, et al.
Pageof 39